Lv2
166 积分 2023-07-15 加入
Trastuzumab rezetecan, a HER2-directed antibody–drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study
8个月前
已完结
Final analysis results and patient-reported outcomes from DESTINY-Lung02—a dose-blinded, randomized, phase 2 study of trastuzumab deruxtecan in patients with HER2-mutant metastatic non–small cell lung cancer
8个月前
已完结
Management of HER2 alterations in non-small cell lung cancer – The past, present, and future
8个月前
已完结
Measurable residual disease detection after CAR-T may predict response in patients with large B-cell lymphoma
9个月前
已关闭
ctDNA dynamics demonstrates rapid treatment response to tafasitamab + R-CHOP +/− lenalidomide and predicts outcome in diffuse large B-cell lymphoma: results from the phase 1b First-MIND study
9个月前
已完结
Circulating tumor DNA from blood and cerebrospinal fluid in DLBCL: simultaneous evaluation of mutations, IG rearrangement, and IG clonality
9个月前
已完结
Distinct epigenetic and transcriptional profiles of Epstein-Barr virus (EBV) positive and negative primary CNS lymphomas
10个月前
已完结
Digital FDG-PET detects MYD88 mutation-driven glycolysis in primary central nervous system lymphoma
10个月前
已完结
Molecular diagnosis of primary CNS lymphoma in 2024 using MYD88Leu265Pro and IL-10
10个月前
已完结
皖公网安备34019202002308
